Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Bromide ion | HCID 259 | — |
| Reactant | Water | HCID 962 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | HCID 86667378 | HCID 86667378 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 86667379 | HCID 86667379 | — |
Reaction Steps
To a solution of 1-[2-chloro-6-morpholin-4-yl-9-(tetrahydro-pyran-2-yl)-9H-purin-8-yl]-ethylamine (0.25 g, 0.68 mmol) in anhydrous DCM were added romoacetyl bromide (62 μL, 0.74 mmol) and triethylamine (0.13 mL, 0.93 mmol). The mixture was stirred at RT. After 2 h, another portion of romoacetyl bromide (12 μL) was added and stirring continued for 1.5 h. Water was added, the phases were separated and the aqueous phase was extracted twice with DCM. The combined organic fractions were dried (Na2SO4), filtered and concentrated in vacuo to give 2-Bromo-N-{1-[2-chloro-6-morpholin-4-yl-9-(tetrahydro-pyran-2-yl)-9H-purin-8-yl]-ethyl}-acetamide (385 mg, mixture of two pairs of diastereomers), which was used in the next step without purification. LCMS RT=3.45 min and 3.52 min, [M+H]+=487/489/491
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08883799B2 |
|---|
| Source dataset | uspto-grants-2014_11 |
|---|
| ORD ID | ord-a19a2dc20b2b41cf896223b3a404f7e3 |
|---|
| Source note | uspto-grants-2014_11 |
|---|